X4 Pharmaceuticals Inc (XFOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 0 | 0 | 3,000 | 0 | 0 |
| Gross Profit | N/A | N/A | 3,000 | N/A | N/A |
| Operating Expenses | 16,980 | 14,658 | 13,581 | 10,875 | 16,976 |
| Operating Income | -16,980 | -14,658 | -10,581 | -10,875 | -16,976 |
| Interest Expense | 697 | 687 | 584 | 548 | 688 |
| Other Income | 228 | 201 | 175 | 586 | -50 |
| Pre-tax Income | -17,449 | -15,144 | -10,990 | -10,837 | -17,714 |
| Income Tax | N/A | N/A | 148 | N/A | N/A |
| Net Income Continuous | -17,449 | -15,144 | -11,138 | -10,837 | -17,714 |
| Net Income | $-17,449 | $-15,144 | $-11,138 | $-10,837 | $-17,714 |
| EPS Basic Total Ops | -26.13 | -22.82 | -16.82 | 128.53 | -36.64 |
| EPS Basic Continuous Ops | -26.09 | -22.70 | -16.71 | 119.55 | -36.53 |
| EPS Diluted Total Ops | -26.13 | -22.82 | -16.82 | 128.53 | -36.64 |
| EPS Diluted Continuous Ops | -26.09 | -22.70 | -16.71 | 119.55 | -36.53 |
| EBITDA(a) | $-16,834 | $-14,592 | $-10,545 | $-10,843 | $-16,949 |